Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Monomeric C-reactive protein-a key molecule driving development of Alzheimer's disease associated with brain ischaemia?

Slevin M, Matou S, Zeinolabediny Y, Corpas R, Weston R, Liu D, Boras E, Di Napoli M, Petcu E, Sarroca S, Popa-Wagner A, Love S, Font MA, Potempa LA, Al-Baradie R, Sanfeliu C, Revilla S, Badimon L, Krupinski J.

Sci Rep. 2015 Sep 3;5:13281. doi: 10.1038/srep13281.

PMID:
26335098
2.

Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.

Bosutti A, Qi J, Pennucci R, Bolton D, Matou S, Ali K, Tsai LH, Krupinski J, Petcu EB, Montaner J, Al Baradie R, Caccuri F, Caruso A, Alessandri G, Kumar S, Rodriguez C, Martinez-Gonzalez J, Slevin M.

PLoS One. 2013 Sep 30;8(9):e75538. doi: 10.1371/journal.pone.0075538. eCollection 2013.

3.

C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression.

Turu MM, Slevin M, Matou S, West D, Rodríguez C, Luque A, Grau-Olivares M, Badimon L, Martinez-Gonzalez J, Krupinski J.

BMC Cell Biol. 2008 Sep 2;9:47. doi: 10.1186/1471-2121-9-47.

4.

Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.

Hussain S, Slevin M, Matou S, Ahmed N, Choudhary MI, Ranjit R, West D, Gaffney J.

Angiogenesis. 2008;11(3):245-56. doi: 10.1007/s10456-008-9108-2. Epub 2008 Mar 11.

PMID:
18330714
5.

Cheiradone: a vascular endothelial cell growth factor receptor antagonist.

Hussain S, Slevin M, Mesaik MA, Choudhary MI, Elosta AH, Matou S, Ahmed N, West D, Gaffney J.

BMC Cell Biol. 2008 Jan 29;9:7. doi: 10.1186/1471-2121-9-7.

6.
7.

Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways.

Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S.

Matrix Biol. 2007 Jan;26(1):58-68. Epub 2006 Sep 19. Review.

PMID:
17055233
8.

Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro.

Matou S, Colliec-Jouault S, Galy-Fauroux I, Ratiskol J, Sinquin C, Guezennec J, Fischer AM, Helley D.

Biochem Pharmacol. 2005 Mar 1;69(5):751-9. Epub 2005 Jan 12.

PMID:
15710353
9.
10.

A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.

Tapon-Bretaudière J, Chabut D, Zierer M, Matou S, Helley D, Bros A, Mourão PA, Fischer AM.

Mol Cancer Res. 2002 Dec;1(2):96-102.

11.

Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro.

Matou S, Helley D, Chabut D, Bros A, Fischer AM.

Thromb Res. 2002 May 15;106(4-5):213-21.

PMID:
12297128
12.

Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.

Tapon-Bretaudière J, Drouet B, Matou S, Mourão PA, Bros A, Letourneur D, Fischer AM.

Thromb Haemost. 2000 Aug;84(2):332-7.

PMID:
10959709
13.

Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.

Giraux JL, Matou S, Bros A, Tapon-Bretaudière J, Letourneur D, Fischer AM.

Eur J Cell Biol. 1998 Dec;77(4):352-9.

PMID:
9930660
14.

Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.

Giraux JL, Tapon-Bretaudière J, Matou S, Fischer AM.

Thromb Haemost. 1998 Oct;80(4):692-5.

PMID:
9798992
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk